Fresenius Medical Care AG (NYSE:FMS) Shares Sold by Legacy Wealth Asset Management LLC

Legacy Wealth Asset Management LLC lowered its stake in Fresenius Medical Care AG (NYSE:FMS) by 1.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,285 shares of the company’s stock after selling 612 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Fresenius Medical Care were worth $731,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Moran Wealth Management LLC raised its holdings in Fresenius Medical Care by 47.0% in the third quarter. Moran Wealth Management LLC now owns 233,376 shares of the company’s stock valued at $4,971,000 after acquiring an additional 74,621 shares in the last quarter. Quantinno Capital Management LP raised its holdings in shares of Fresenius Medical Care by 78.9% in the 3rd quarter. Quantinno Capital Management LP now owns 110,078 shares of the company’s stock valued at $2,345,000 after purchasing an additional 48,554 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Fresenius Medical Care by 3.3% during the 3rd quarter. Franklin Resources Inc. now owns 74,640 shares of the company’s stock worth $1,490,000 after purchasing an additional 2,386 shares during the last quarter. Crossmark Global Holdings Inc. lifted its position in shares of Fresenius Medical Care by 60.4% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 62,889 shares of the company’s stock worth $1,340,000 after purchasing an additional 23,692 shares during the last quarter. Finally, Creative Planning grew its stake in shares of Fresenius Medical Care by 18.9% during the second quarter. Creative Planning now owns 40,140 shares of the company’s stock worth $766,000 after purchasing an additional 6,373 shares in the last quarter. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care Stock Down 0.3 %

FMS opened at $23.09 on Friday. Fresenius Medical Care AG has a one year low of $17.93 and a one year high of $24.31. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The stock has a market capitalization of $13.55 billion, a P/E ratio of 19.08, a price-to-earnings-growth ratio of 0.72 and a beta of 0.92. The business’s 50-day simple moving average is $22.67 and its 200-day simple moving average is $20.86.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on FMS shares. Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a report on Monday, December 2nd. Truist Financial upped their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a report on Monday, January 6th. StockNews.com initiated coverage on shares of Fresenius Medical Care in a research note on Friday, January 3rd. They issued a “strong-buy” rating on the stock. Finally, Berenberg Bank initiated coverage on shares of Fresenius Medical Care in a research report on Wednesday, November 6th. They set a “buy” rating and a $25.60 price objective for the company.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.